Norgestrel and ethinyl estradiol and Vaginal bleeding - a phase IV clinical study of FDA data
Vaginal bleeding is found among people who take Norgestrel and ethinyl estradiol, especially for people who are 40-49 old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Norgestrel and ethinyl estradiol and have Vaginal bleeding. It is created by eHealthMe based on reports of 302 people who have side effects when taking Norgestrel and ethinyl estradiol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
302 people reported to have side effects when taking Norgestrel and ethinyl estradiol.
Among them, 15 people (4.97%) have Vaginal bleeding.
What is Norgestrel and ethinyl estradiol?
Norgestrel and ethinyl estradiol has active ingredients of ethinyl estradiol; norgestrel. eHealthMe is studying from 302 Norgestrel and ethinyl estradiol users for its effectiveness, alternative drugs and more.
What is Vaginal bleeding?
Vaginal bleeding is found to be associated with 2,478 drugs and 1,132 conditions by eHealthMe.
Number of Norgestrel and ethinyl estradiol and Vaginal bleeding reports submitted per year:
Time on Norgestrel and ethinyl estradiol when people have Vaginal bleeding *:
Age of people who have Vaginal bleeding when taking Norgestrel and ethinyl estradiol *:
Common drugs people take besides Norgestrel and ethinyl estradiol *:
Common side effects people have besides Vaginal bleeding *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Norgestrel and ethinyl estradiol and have Vaginal bleeding?Check whether Vaginal bleeding is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Vaginal bleeding and when was it recovered:
Expand to all the drugs that have ingredients of ethinyl estradiol; norgestrel:
Alternative drugs to, pros and cons of Norgestrel and ethinyl estradiol:
- Norgestrel and ethinyl estradiol (302 reports)
Common Norgestrel and ethinyl estradiol side effects:
- Drug ineffective: 115 reports
- Unintended pregnancy (unwanted pregnancies as well as those that are mistimed): 111 reports
Browse all side effects of Norgestrel and ethinyl estradiol:a b c d e f g h i j k l m n o p q r s t u v w x y z
Vaginal bleeding treatments and more:
- Vaginal bleeding (46,232 reports)
COVID vaccines that are related to Vaginal bleeding:
- Vaginal bleeding in Moderna COVID Vaccine
- Vaginal bleeding in Pfizer BioNTech Covid Vaccine
- Vaginal bleeding in Johnson and Johnson Covid Vaccine
Common drugs associated with Vaginal bleeding:
All the drugs that are associated with Vaginal bleeding:
- Vaginal bleeding (2,478 drugs)
Common conditions associated with Vaginal bleeding:
All the conditions that are associated with Vaginal bleeding:
- Vaginal bleeding (1,132 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ethinyl estradiol; norgestrel (the active ingredients of Norgestrel and ethinyl estradiol) and Norgestrel and ethinyl estradiol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gemzar and Nabumetone drug interaction - now
- Magnesium and Viokace drug interaction - now
- Talwin vs. Nubain - 4 seconds ago
- Orange and Cough Aggravated - 6 seconds ago
- Navane and Glaucoma - 8 seconds ago
- Weight Loss and Cerebral Venous Thrombosis - 11 seconds ago
- Perindopril Erbumine and Diclofenac Sodium drug interaction - 11 seconds ago
- Tolsura and Appetite - Decreased - 14 seconds ago
- Tolsura and Appetite Decreased - 14 seconds ago
- Loxapine and Haematoma - 19 seconds ago